CERIBELL INC
CBLLNASDAQ🏆 #2355 by market capEarnings Nov 3 · PostUS Equity
$27.80▲ $0.55 (+2.00%)
Latest quoteTrack CBLL
Get earnings, price moves & breaking news on Telegram
24h▲ 2.0%
7d▲ 1.4%
14d▲ 0.5%
30d▲ 11.9%
ytd▲ 26.9%
1y▲ 131.3%
🏦Market Cap
$1.07B
Small Cap
📈Revenue Growth (YoY)
36.1%
High Growth
📊Gross Margin
88.9%
High
💵FCF Margin
-55.3%
Thin
⚖️P/S Ratio
10.2x
Elevated
Otter Score
64
Fair
Trading Snapshot
- Day Range
- $27.40 – $28.02
- 52-Week Range
- $10.85 – $28.11
- Volume (shares)
- 15,002
- Avg Volume (shares)
- —
- Shares Outstanding
- 38.4M
- Next Earnings
- 2026-11-03
Fundamentals Snapshot
- Annual Revenue
- $89M
- Last Q Revenue
- $28M
- P/E Ratio
- -15.5
- P/S Ratio
- 10.2x
- EPS (TTM)
- $-1.74
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +19.3%
CERIBELL INC
CBLLFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$89M▲ +36.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
87.9%▲ +1.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$58M▲ +47.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$42M▲ +14.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
37.2M▲ +19.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$18M▼ −$154M YoY
StockOtter · stockotter.spaceAbout CERIBELL INC
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100
Analyst Ratings
ⓘConsensus
Buy
14 analysts
Strong Buy7
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.